Sensex Today Trades Lower | Nifty Below 24,550 Level | Zee Entertainment Declines 6%, Hindustan Aeronautics 5%

Thu, 18 Jul 10:30 am

   Previous Close   

   Pre-Open   

   Closing   

Asian equities fell on Thursday, led by chip stocks as investors fret over the prospect of escalating trade tensions between the US and China, while the yen surged to a six-week high in the wake of suspected interventions by Tokyo last week.

MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.57%, with tech heavy South Korean shares down nearly 1%.

US stock market ended mixed on Wednesday with the S&P 500 and the Nasdaq suffering heavy losses as tech stocks plunged.

Here's a table showing how US stocks performed on Wednesday:

Stock/Index	LTP	Change ($)	Change (%)	Day High	Day Low	52-Week High	52-Week Low
Alphabet	182.62	-2.88	-1.55%	185.23	181.62	193.31	118.69
Apple	228.88	-5.94	-2.53%	231.46	226.64	237.23	164.08
Meta	461.99	-27.8	-5.68%	479.17	459.12	542.81	274.38
Tesla	248.5	-8.06	-3.14%	258.47	246.18	299.29	138.8
Netflix	647.46	-8.86	-1.35%	650.45	639.47	697.49	344.73
Amazon	187.93	-5.09	-2.64%	191.58	185.99	201.2	118.35
Microsoft	443.52	-6	-1.33%	444.85	439.18	468.35	309.45
Dow Jones	41198.08	243.6	0.59%	41221.98	40849.71	41221.98	32327.2
Nasdaq	19799.14	-599.48	-2.94%	20080.27	19793.75	20690.97	14058.33

Source: Equitymaster

At present, the BSE Sensex is trading 162 points lower and NSE Nifty is trading 46 points lower.

ONGC, Sun Pharma and Axis Bank among the top gainers today.

Bajaj Auto, Coal India and Adani Ports the other hand are among the top losers today.

For a comprehensive overview of key players in the financial sector, check out list of Fin Nifty Companies.

For impact of the Bank Nifty companies and comprehensive overview of the index, check out Equitymaster's Bank Nifty Companies list.

Broader markets are trading on negative note. The BSE Midcap index is trading 1.2% lower and the BSE Smallcap index is trading 1.4% lower.

Sectoral indices are trading on negative note today, with stocks in metal sector and energy sector witnessing most selling pressure.

The rupee is trading at Rs 83.57 against the US dollar.

In commodity markets, gold prices are trading 0.3% higher at Rs 74,390 per 10 grams today.

Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...

Speaking of the stock market, there is set to be a wide demand supply gap in power availability over the next decade. So, most power producers are betting on an attractive increase in merchant power tariffs over next five years.

And therefore, there is an unwillingness to sign long term power purchase agreements (PPAs) at relatively lower prices.

So, what does it mean?

Tanushree Banerjee, Research Analyst in her latest video talks hidden opportunities for long term investors.

Tune into below video for more details.

IREDA's Nepal Investment Plan

State-owned IREDA on Wednesday said the company will invest Rs 2.9 bn in a 900 MW hydroelectric power project in Nepal. The Board of Directors of IREDA gave in-principle approval for the equity investment at a meeting on Tuesday.

Indian Renewable Energy Development Agency Ltd. (IREDA) has received approval for Rs 2.9 bn equity investment for up to 10% stake in special purpose vehicles (SPVs) in association with state-run hydropower generating company SJVN.

The above will be subject to approval from the central government, and other statutory and regulatory authorities, as applicable.

IREDA also plans to become a "Maharatna" PSU by the end of the financial year 2030, for which it has laid out growth targets for itself.

Indian Renewable Energy Development Agency, founded in March 1987, is a Navratna PSU. It is administratively controlled by the Ministry of New and Renewable Energy (MNRE).

Tata Power's Renewable Energy Drive

Tata Power Co. Ltd plans to invest around Rs 200 bn in the current fiscal year, chairman N. Chandrasekaran said at the company's 105th annual general meeting (AGM) on Friday.

The bulk of this investment will bolster its renewable energy business, with the rest earmarked for transmission and distribution operations.

This is over and above the Rs 120 bn invested in FY24. A large part of this will be towards accelerating the company's renewable energy portfolio and balance towards transmission and distribution businesses.

The company will also explore opportunities in small modular nuclear reactors, once the government gives necessary permissions, along with new distribution opportunities in other states, as and when these opportunities arise, said Chandrasekaran.

It serves 12.5 million consumers through its distribution business and is targeting to reach 50 million.

The Tata Group company is well positioned to lead India's green energy shift with a focus on providing round-the-clock renewable energy, especially to commercial and industrial (C&I) consumers.

The company is also aiming to increase its market share in the rooftop solar space under the PM Surya Ghar Yojana and enhance its renewable energy portfolio from the current 9 GW to 15 GW within five years.

Glenmark Pharma Receives USFDA Approval

Glenmark Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for Topiramate capsules.

The approved drug is bioequivalent and therapeutically equivalent to Topamax capsules of Janssen Pharmaceuticals and will be distributed in the U.S. by Glenmark Therapeutics Inc., USA.

Topiramate is used alone or with other medications to treat certain types of seizures including primary generalized tonic-clonic seizures and partial onset seizures. It is also used with other medications to control seizures in people who have Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays) as well as to prevent migraine headaches but not to relieve the pain of migraine headaches when they occur in adults and children 12 years of age and older.

According to IQVIA, the Topamax Capsules market achieved annual sales of approximately $21.9 million sales for the 12 months ending May 2024.

Glenmark's current portfolio consists of 198 products authorized for distribution in the U.S. marketplace and 50 ANDAs pending approval with the U.S. FDA.

Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company with a presence across speciality, generics and OTC businesses.

Glenmark Pharma is actively involved in the discovery of new molecules, NCEs (new chemical entity) and NBEs (new biological entity).

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers